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STRUCTURE OF THESIS 
 
This thesis is structured into five chapters. The first chapter is an introduction to the thesis work 
which outlines the research questions being investigated, the purpose of the research and the 
specific research aims.  
 
The second chapter presents a literature review on recent studies of socioeconomic disparities in 
cancer survival, including an examination of temporal trends in these disparities, to provide context 
for the following publications.  
 
The body of this thesis consists of chapters three and four, which comprise two original research 
papers. Chapter three is our submitted manuscript “Cancer survival in New South Wales, Australia: 
Socioeconomic disparities remain despite overall improvements” (BMC Cancer, 2015). This 
chapter analyses trends in socioeconomic survival disparities over time for ten major cancers in 
New South Wales (NSW), highlighting priority groups and the potential impact of minimising these 
disparities. 
 
The fourth chapter is our submitted manuscript “Impact of geographic area level on measuring 
socioeconomic disparities in cancer survival in New South Wales, Australia” (Cancer 
Epidemiology, 2015). This paper presents our comparison of two different area-units, Local 
Government Areas (LGA) and census Collection Districts (CD), for measuring socioeconomic 
disparities in cancer survival detected in NSW and investigates the extent of misclassification by 
socioeconomic status (SES) that may occur between these two area units, to determine which unit 
is the better alternative for measuring socioeconomic survival disparities. 
 
The final chapter is a comprehensive discussion of the research conducted and conclusions drawn 
from this work. I consider many proposed reasons for cancer survival disparities by socioeconomic 
status and discuss how the use of different geographic area units can impact on the survival 
disparities detected. I summarise the findings of my research and discuss the wider implications of 
this thesis, including identifying specific cancers types that require additional attention to improve 
survival, and the potential for both cancer registry data and other population based data sources to 
utilise various small geographic units to improve future accuracy. 
 
In addition, there are sections with acknowledgements, an abstract, the author’s contribution, and 
appendices containing statements from the co-authors of the included manuscripts and 
supplementary material related to these manuscripts. 
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ABSTRACT 
 
Many studies in developed countries around the world have reported variations in cancer survival 
associated with socioeconomic status. Understanding the causes of survival disparities is of 
continued interest to inform interventions targeting these socioeconomic disparities, as well as 
monitoring survival trends over time to evaluate the effectiveness of such interventions. 
 
Cancer survival is a useful measure in the evaluation of cancer control efforts, giving a quantifiable 
measure of the effectiveness of diagnostic and treatment services, and the management of cancer 
care services. Ecologic analyses are widely used as the preferred approach for evaluating the 
effectiveness of a population intervention. Increased socioeconomic variability within geographic 
area-units makes it difficult to isolate the discrete effect of socioeconomic status on cancer 
survival, particularly when using few, or large, geographic units. Despite recent research interest in 
socioeconomic disparities in cancer outcomes, NSW cancer-registry data has not been used to 
track temporal trends in survival disparities for many years. Furthermore, no study investigating 
how the geographic area-level at which SES is measured impacts the survival disparities detected,  
The body of this thesis includes two original research articles addressing these two concerns. The 
first is under consideration for publication by BMC Cancer (minor revisions submitted 24 
December, 2015. And the second is under consideration with Cancer Epidemiology (revision 
submitted 23 December, 2015.  
 
The first article analyses trends in socioeconomic survival disparities over time for ten major 
cancers in New South Wales, demonstrating that recent health and social policies in NSW have 
accompanied an increase in cancer survival overall, but they have not been associated with a 
reduction in socioeconomic inequalities. Socioeconomic disparities persisted in NSW over the 
study period while a large number of deaths attributable to a diagnosis of cancer could have been 
postponed if these disparities were eliminated. The second article compares of two different area-
units for measuring socioeconomic disparities in cancer survival in NSW, showing that while 
patient SES classification differed between area-units, the impact on cancer survival disparities of 
SES misclassification when using the larger area-unit was relatively small and inconsistent.  
 
Overall, this thesis emphasizes the importance of assessing progress toward eliminating cancer 
survival inequalities. The findings of this thesis have important implications for predicting and 
planning for the future needs of cancer care services in NSW, thus informing health and social 
policies aiming to reduce the socioeconomic inequalities in cancer survival in NSW. This thesis 
also contributes to the field of epidemiology by improving our understanding of the impact of using 
area-based measures of differing geographical precision when investigating socioeconomic 
inequalities in health outcomes.	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CHAPTER 1: INTRODUCTION 
 
ABOUT THIS CHAPTER 
 
This chapter presents the background for this thesis. Firstly, I explain the purpose of conducting 
this research and define the aims of the thesis. The subsequent section provides a brief overview 
of the use of area-based or ‘ecological’ studies, and their usefulness in investigating 
socioeconomic variations in cancer survival at the population level, to provide context for the 
following chapters.  
 
 
AIMS 
 
The purpose of conducting research for this thesis is to investigate the associations between 
socioeconomic status (SES) and cancer survival in the state of New South Wales (NSW), 
Australia. The primary aim of this thesis is to provide up-to-date information on the socioeconomic 
differentials in cancer survival in NSW. This research will also estimate the number of lives 
potentially extendable beyond 5 years if no socioeconomic differentials in cancer survival existed in 
NSW. The secondary aim of this thesis is to compare two geographic area-based units for 
classifying patients according to SES and estimate the degree of patient misclassification between 
these units and the impact of such misclassification on measuring socioeconomic disparities in 
cancer survival.  
 
BACKGROUND 
 
Many studies in developed countries around the world have reported variations in cancer survival 
associated with socioeconomic status, in which patients from more socioeconomically 
disadvantaged backgrounds show poorer survival rates for many major cancers (1-4). Research 
into understanding the causes of such survival disparities is of continued interest, to inform the 
development of interventions to reduce and ultimately eliminate these socioeconomic disparities. 
There is also increasing research focus on monitoring survival trends over time to evaluate the 
effectiveness of these interventions to reduce these disparities.  
 
Ecologic analyses are widely used as the preferred approach for evaluating the effectiveness of a 
population intervention (5). Cancer survival is a useful measure in the evaluation of cancer control 
efforts, giving a quantifiable measure of the effectiveness of diagnostic and treatment services, and 
the management of cancer care services. Using population-based cancer registry data allows us to 
measure survival rates at the population level, as well as consider important information such as 
patient age, sex, stage of disease and residential location at diagnosis in our analyses. By 
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monitoring temporal and socioeconomic trends in patient survival, we can assess priorities and 
equity in cancer care services, inform health resource management and evaluate the potential for 
future improvements in cancer control strategies.  
 
As is common for population-based registry data, relative survival will be used in this study to 
calculate survival estimates, as described previously (6). Relative survival compares the survival 
rate of cancer patients to that of people in comparable group, usually the general population. That 
is, it removes the effect of the ‘background’ mortality rate, or mortality from other causes (7). Thus 
relative survival provides a measure of excess mortality due to a diagnosis of cancer. As it can be 
difficult to determine the degree to which a patient’s death is due specifically to their cancer 
diagnosis, this approach provides a more objective and possibly more accurate means of removing 
the effect of mortality from other causes (8). Using relative survival also removes the need to 
obtain specific cause of death information for cancer patients, which is often incomplete or 
inaccurate in population-based cancer registries (9, 10).  
 
Ecological studies use a group as the unit of analysis, typically defined by a geographic area. They 
allow large datasets to be analysed efficiently, in a more cost effective and less time consuming 
manner than studies using individual level data. Area-based measures of the SES of individual 
patients are widely used in health research since individual level information is not available in 
population-based studies. However, analysis issues can arise here due to varying sizes of areas, 
and thus of populations within groups. Additionally, data on many important individual variables 
such as treatment regime, patient lifestyle factors and socioeconomic information are not available, 
since population-based cancer registries do not collect this information. Increased socioeconomic 
variability within geographic area-units makes it difficult to isolate the discrete effect of 
socioeconomic status on cancer survival, particularly when using few, or large, geographic units. 
As a result, misclassification of patients can occur when using aggregated data, such that 
ecological studies of cancer survival are subject to limitations, particularly when interpreting results. 
This inferential problem can be minimised by creating groups as socioeconomically homogenous 
as possible, by using small area units for classification and then aggregating for analysis, thereby 
ensuring a more valid and precise estimate of effect. 
 
Previous research in Australia has shown that more disadvantaged patients experience poorer 
survival rates than the least disadvantaged patients (6, 11, 12). Such studies commonly use 
aggregate estimates of socioeconomic status obtained from national census data of the Local 
Government Area (LGA) of a patient’s address. LGAs in Australia vary greatly in both area and 
population size, ranging from small urban areas with very large populations to extremely large rural 
areas with small populations. Using LGAs for SES classification therefore may potentially result in 
misclassification of many cancer patients according to SES, as observed in similar studies where 
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larger area-units have been used (13-16). Consequently, the true socioeconomic disparities in 
cancer survival in NSW may vary from those previously reported.  
 
Cancer data from the population-based NSW Central Cancer Registry became available that would 
allow us to use the smaller geographic area unit of census collection district (CD) for SES 
classification. CDs were the smallest geographic area unit used by the Australian Bureau of 
Statistics (ABS) until 2011 and are known to represent a more socioeconomically homogenous 
population than LGAs (17). Comparing analyses of LGA and CD level data could identify the extent 
to which cancer cases may be misclassified according to SES when investigating socioeconomic 
disparities in cancer survival.  
 
Despite recent research interest in socioeconomic disparities in cancer outcomes, there has been 
limited work monitoring cancer survival disparities in NSW. NSW cancer-registry data has not been 
used to track temporal trends in cancer survival disparities for many years. Furthermore, no study 
investigating how the geographic area-level at which SES is measured impacts the survival 
disparities detected, comparing the units of LGA and CD, has been published in Australia. In this 
thesis, I report on temporal trends in cancer survival in NSW, using the most recent available 
cancer registry data to provide the most informative results. I then investigate the impact on the 
observed socioeconomic variation in cancer survival rates from using two different geographic 
area-level units for classifying patients according to socioeconomic status. 
 
Chapter 2 is a literature review of recent studies investigating temporal trends in socioeconomic 
disparities in cancer survival, both locally and internationally, and examines the various effects of 
area-level socioeconomic classification on measuring cancer survival disparities. Chapter 3 
presents comprehensive analysis of temporal trends in socioeconomic cancer survival disparities 
in NSW and explores many proposed reasons for these disparities. In Chapter 4 I demonstrate the 
effect of using different area-level units to classify patient socioeconomic status, and show how 
misclassification of patient SES can impact the survival and risk estimates in such analyses. In 
Chapter 5, I examine all the findings from this thesis as a whole and discuss what new knowledge 
this research contributes to the field of cancer epidemiology.  
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CHAPTER 2: LITERATURE REVIEW 
 
ABOUT THIS CHAPTER 
 
In this chapter I provide a detailed review of the previous studies of socioeconomic inequalities in 
cancer survival, including the few recent studies that monitor temporal trends in these inequalities. 
I chose to limit this review to studies published from 2006 onwards, after the last major review of 
socioeconomic inequalities in cancer survival was published (1), up to the end of 2014. I also 
limited the included studies to those which used population-based cancer registry data and 
included 3 or more years of patient follow-up for calculating survival. I further limited the selected 
studies to those which examine one or more of the cancers to be considered in this thesis, these 
being stomach, colorectal, liver, lung, melanoma of the skin, female breast, cervical, uterine, 
ovarian and prostate cancers. Studies that fulfill these requirements are of most relevance to the 
context of this thesis.   
 
 
SOCIOECONOMIC INEQUALITIES IN CANCER SURVIVAL 
 
Several population-based studies have been conducted investigating socioeconomic inequalities in 
survival for stomach (2-9), colorectal (2-7, 9-15), liver (3, 4, 9, 16), lung (2-7, 9, 11), melanoma of 
the skin (2, 4-7, 9), female breast (2-7, 9, 11, 14, 17-20), cervical (2-7, 9, 11, 21, 22), uterine (2-7, 
9, 22), ovarian (2-7, 9) and prostate (2-7, 9, 23) cancers since 2006. Several of these studies 
examined multiple, typically common cancer types to provide an overview of survival inequalities, 
while others conducted detailed analyses of inequalities in survival for a single cancer site. A 
summary of the studies included in this review, detailing the location, outcome measure(s), 
socioeconomic measure(s) and main results, is provided in Table 1.  
 
Among the studies examining individual cancer types, most investigated survival inequalities in 
more common cancers, particularly colorectal (10, 12-15) and breast (14, 17-20), which both 
contribute greatly to prevalence and cancer-related mortality in populations. Additionally, 
socioeconomic survival disparities would be likely to exist for these cancers due to the availability 
of early diagnostic techniques and effective treatments for early stage disease. Socioeconomic 
disparities in survival from colorectal cancer have been reported in studies from the UK (12, 14, 
15), the US (13) and Australia (10). In a study of 181,359 patients diagnosed with colorectal cancer 
between 1996 and 2004 in England, Moller et al reported 4-7% lower survival from colon cancer in 
the most deprived group compared to the most affluent, and a 6-15% survival difference for rectal 
cancer. Most of this survival variation was observed within 2 years of diagnosis, after which small 
survival disparities persisted, but had little association with patient SES (15). Jeffreys and 
colleagues also investigated survival disparities for rectal cancer using data from 132,542 patients 
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in England and Wales, reporting 5-year relative survival in the most deprived SES group at 45.5% 
compared to 53.8% in the most affluent SES group for patients diagnosed between 1996 and 
1999, however the effect of deprivation on survival was most pronounced in the first year after 
diagnosis (12). Similar disparities were found by Lyratzopoulos et al, whose study extended the 
analysis by Jeffreys up to 2007. They reported a deprivation gap in survival of -11% between the 
highest and lowest SES groups by 2007, using data from 187,104 men with rectal cancer in 
England (14). The inequalities found in all three of these studies however are likely to be due in 
part to the impact of differential stage at diagnosis, which could not be accounted for as UK cancer 
registries do not routinely collect stage data. In California, Le and colleagues reported lower 
survival for both colon and rectal cancer in lower socioeconomic groups, in a study of 90,273 colon 
and 37,532 rectal cancer patients diagnosed in the ten years 1994-2003. The authors noted 
however that part of their observed survival inequalities were likely attributable to differences in 
treatment by SES, specifically treatment refusal, which was strongly associated with low SES in 
multivariate analysis (13). In Australia, Baade and colleagues recently reported significant 
associations between socioeconomic disadvantage and poorer cancer-specific and all-cause 
survival in colorectal cancer patients after adjusting for multiple factors including disease stage and 
clinical data (10).  
 
Several studies have also examined inequalities in breast cancer survival by socioeconomic status 
in the US (18, 20), UK (14), New Zealand (19) and Australia (17). Using data from the US National 
Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program from 1987-2004, 
Harper et al reported that women over 50 of lower SES experienced higher cause-specific 
probability of death (100 – survival rate) from breast cancer compared to women of high SES. This 
was likely influenced by the higher rates of late stage disease found in lower SES women, who 
were the least likely to attend mammography screening (18). Tannenbaum and colleagues found 
similar results using data from Florida, where an incremental improvement in survival was found for 
each higher SES group compared to the lowest in 3- and 5-year survival analyses (p<0.001) after 
adjustment for race, comorbidity, stage, tumour grade, node status, treatments and demographic 
variables (20). In addition to rectal cancer, Lyratzopoulos and colleagues studied data from 
921,611 women with breast cancer in England and reported a deprivation gap in survival of -6% 
between the highest and lowest SES groups by 2007. However, this study could not account for 
stage in the analysis, so the introduction of breast cancer screening in the UK during the study 
period is likely to have contributed to the disparities observed (14). McKenzie et al studied 
inequalities in survival for 2,968 women with breast cancer in New Zealand and found that lower 
survival rates in more deprived women, as well as significantly higher excess mortality in the four 
most deprived groups compared to the four least deprived (19). Similarly in Australia, Dasgupta 
and colleagues examined data from Queensland and found a 5-year relative survival rate in the 
most disadvantaged group of 89.9% compared to 93.4% in the least disadvantaged (p<0.001). The 
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authors also reported significantly increased risk of breast cancer-specific death in the most 
deprived socioeconomic group (p=0.032), after adjusting for stage of disease and patient 
characteristics (17). 
 
Other studies that examined survival inequalities in individual cancers focused on stomach (8), 
liver (16), cervical (21, 22), uterine (22) and prostate (23) cancers. In a study of stomach cancer 
patients in the north-east of the Netherlands, Seimerink et al examined survival inequalities in the 
period 1989-2009 for 9,239 patients, reporting that the RER of death of high SES patients was 
significantly reduced compared to low SES patients, a difference that could not be explained by 
stage or treatment factors (8). Yu et al also found significantly lower relative survival in low SES 
patients with stomach cancer in Australia (9). Ueda and colleagues investigated disparities in 
survival for 3,113 patients with uterine cancer in Osaka, Japan, finding significantly lower 5-year 
relative survival for women in lower SES groups compared to the highest SES group, when using 
both education level and unemployment level SES measures (both p<0.0001). The same study 
also reported significant survival inequalities between socioeconomic groups of low and high 
unemployment, for 14,055 patients with cervical cancer (22). Similarly, Eggleston et al found 
significantly shorter survival time for low SES women diagnosed with both early (p<0.001) and late 
(p<0.001) stage cervical cancers in Texas between 1995 and 2001 (21). For prostate cancer, Yu et 
al reported that men living in more disadvantaged areas of NSW having significantly higher 
mortality risk than those living in the least disadvantaged areas (p<0.001) (23). In contrast to 
others cancers however, no disparities in survival from liver cancer were in Canada by Jembere 
and colleagues, who analysed 5,481 patients diagnosed during 1990-2001 in Ontario. The authors 
found no significant difference in median survival time between income-based socioeconomic 
quintiles. A slightly decreased mortality risk was initially detected in the 3 highest income quintiles, 
which then became insignificant after adjusting for curative intent treatment, suggesting that higher 
rates of curative intent treatment in higher income groups explained their survival advantage (16). 
 
Among the studies that examined survival inequalities for multiple cancer types, survival rates were 
generally found to be lower in more deprived or lower socioeconomic groups for the majority of 
cancers. Typically these studies investigated more frequently occurring cancers such as colon and 
rectal, lung, breast and prostate cancers, as well as those of good prognosis such as melanoma, 
cervical and uterine cancers. These studies used data from a diverse range of international 
contexts, including Canada (11),  the United Kingdom (6, 7), Japan (3), several European countries 
(2, 4, 5) and Australia (9), reflecting the widespread nature of socioeconomic survival inequalities.  
 
Using data from all 3.22 million Danish residents, Dalton et al investigated disparities in survival by 
level of education and disposable income, for cancers diagnosed during 1994-2003. The authors 
reported marked differences in relative survival for many cancers, including colon, breast, cervical 
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and prostate cancers, patients with basic education and lower income having poorer survival. For 
cancers of poorer prognosis such as lung and ovarian cancers, small survival disparities were only 
observed in the short term (<1 year) after diagnosis (2). Jansen et al reported similar results in 
their analysis of pooled data on 983, 601 cancer patients from 200 federal state districts in 
Germany. This study found significantly lower 5-year relative survival for 21 of 25 cancer sites in 
the most deprived districts (p<0.0001) during 2003-2006, after adjusting for cancer stage (4). 
Similarly, Pokhrel and colleagues found less educated patients in Finland had lower survival for 
nearly all cancers sites considered between 1971 and 2005, though these differences were due in 
part to less favourable stage distribution in lower educated patients (5). Shack and colleagues in 
Scotland reported that 5-year overall survival was lower in more deprived patients for 25 of 30 
cancer-sex combinations diagnosed during 1996-2000 (7). In Canada, Booth et al found 
significantly lower overall survival in the poorest communities in Ontario (11), while Ito et al in 
Japan reported significant deprivation gaps in survival for 16 of 20 cancer-sex combinations. In 
striking contrast to evidence of wider disparities in the short-term following diagnosis from other 
locations, these survival inequalities in Japan tended to widen with time since diagnosis. The 
authors suggested this could possibly due to under-staging of cancers and/or non-optimal 
management of patients (3). Finally, Yu and colleagues investigated relative survival inequalities 
for 13 common cancers in New South Wales, Australia, reporting 10-20% lower survival in more 
educationally disadvantaged groups (9). 
 
Survival disparities for several cancers were only examined in these studies of multiple sites, 
including lung cancer, melanoma of the skin and ovarian cancer. These cancers are studied less 
as they generally have poorer prognosis (lung and ovarian cancer) or are not seen as a cancer of 
priority internationally (melanoma). Despite the overall poor survival, lower socioeconomic groups 
were shown to experience significantly lower survival from lung cancer in Australia (9), Germany 
(4) and Japan (3). Evidence for survival inequalities for melanoma however was inconsistent 
between studies, with Dalton et al in Denmark and Jansen et al in Germany both reporting 
significantly lower survival in lower SES groups (2, 4), and Shack and colleagues finding significant 
disparities in women diagnosed in Scotland (7). Conversely, no survival differences between SES 
groups were reported by Yu et al in Australia (9). Ovarian cancer survival also showed inconsistent 
disparities between studies, with no difference or small, insignificant inequalities found in Denmark  
(2), Scotland (7), Germany (4) and Australia (9), but significant disparities in survival found 
between SES groups in Japan (3) and Finland (5).  
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TEMPORAL TRENDS IN SOCIOECONOMIC INEQUALITIES IN CANCER SURVIVAL 
 
Among the studies included in this review, 7 studies examined temporal trends in the survival 
inequalities detected (3, 5-7, 12, 14, 18). In general, improved survival was seen for the majority of 
cancers over time, but changes reported in socioeconomic inequalities in survival were 
inconsistent between studies.  
 
Examining long-term trends in survival inequalities, Lyratzpoulos et al thought to identify whether 
the advent of major treatments was followed by narrowing widening of the inequalities (14). For 
women with breast cancer in England and Wales, relative survival increased steadily over time with 
improvements seen in each deprivation group. The deprivation gap in survival between more 
affluent and deprived groups decreased gradually over the study period 1973-2004. Lyratzpoulos 
and colleagues suggested that most of the reduction in breast cancer mortality observed was 
attributable to wider availability and use of chemotherapy and endocrine therapy, which coincided 
with the study period. Additionally for men with rectal cancer, Lyratzpoulos et al observed improved 
survival over study period and improved in each deprivation group, but not at the same pace. As 
such, the deprivation gap in rectal cancer survival widened over the study period. These widening 
inequalities were thought to be caused by combination of differential SE trends in earlier diagnosis 
and clinical management developments, such as surgical specialization and treatment advances 
(14). Concordant with Lyratzpoulos’ study, Rachet et al reporting improved survival for most 
cancers in England during the introduction period of the National Health Service (NHS) cancer plan 
(2000), but wide survival inequalities remained for many cancers by the end of their study in 2006 
(6). Similarly, improved survival over time for rectal cancer in England and Wales was reported by 
Jeffreys and colleagues, but survival inequalities were found to have widened between 1986 and 
2001 by approximately 5% between affluent and deprived groups (12). In Scotland, survival 
improved overall but the deprivation gap in survival widened between 1986 and 2000 for 15 of the 
20 cancers studied, including uterine and prostate cancers. No change in survival disparities was 
observed for breast, ovarian or cervical cancers, but the deprivation gap decreased for men with 
stomach cancer (7).  
 
Statistical modelling by Pokhrel et al showed that the higher cancer-specific and relative survival 
rates generally observed among highly educated patients in Finland had persisted over time during 
1971-2005 (5). In Japan, Ito and colleagues reported increased survival for most cancers over the 
study period 1993-2004, excluding cervical, uterine, ovarian and colorectal cancers in women, and 
stomach cancer in both sexes, which all saw no survival improvement. Interestingly, again contrary 
to general trends seen in other locations, no change in the deprivation gap in 5-year survival was 
observed over the study period for the majority of cancers, only small reductions in one-year 
12 
survival for stomach cancer in women and lung cancer in men (3). Finally, since 1987, absolute 
socioeconomic disparities in cause-specific probability of death from breast cancer in the US 
declined overall by 20%, with improvements seen in all socioeconomic groups. More 
disadvantaged groups however improved at a slower rate, evidenced by increasing relative 
disparity between socioeconomic groups. The authors proposed that a lack of adequate health 
insurance and not having a usual source of health care were likely important barriers to appropriate 
care in these groups (18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Sum
m
ary of included studies by cancer type 
14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
FACTORS CONTRIBUTING TO SOCIOECONOMIC INEQUALITIES IN CANCER SURVIVAL 
 
The causes of inequalities in cancer survival by SES are not thoroughly understood. Variations in 
diagnosis, treatment, health care system features and patient characteristics, may contribute. 
 
Stage of disease at diagnosis is a significant predictive factor for cancer survival. Significant 
differences in the distribution of stage by SES have been reported in Australia, with low SES 
patients more often presenting at a later stage (24). Population-based cancer screening programs 
have been successful in improving survival rates, primarily through increased diagnosis of small 
and early stage cancers (24-27). However, lower rates of screening participation generally occur in 
more disadvantaged socioeconomic groups, (18, 25, 28, 29). Variation in cancer treatment by SES 
may also contribute to disparities in survival, as patients of lower SES more often receive sub-
optimal or non-guideline therapy (8, 30-33). Reduced compliance with recommended treatment 
regimes in low SES patients may also contribute to lower survival rates (34, 35). Organisation of 
the health care system has also been shown to impact on cancer survival inequalities, where 
patients with access to universal health care experience smaller survival inequalities compared to 
those whose care is provided on a fee-for-service basis (36-38). 
 
Patient lifestyle factors impact on cancer survival mainly by affecting overall health (39, 40). Recent 
reports have found that patients from lower socioeconomic areas had significantly higher 
occurrences of poor lifestyle behaviours including smoking, risky alcohol consumption and 
insufficient physical activity (41, 42). Some lifestyle factors such as smoking have been shown to 
directly impact on the benefits of cancer treatment (43, 44). Lifestyle factors also impact on the 
occurrence of other chronic diseases, known as comorbidities. Variation in comorbidities between 
socioeconomic groups may partly explain socioeconomic inequalities in cancer survival, as lower 
socioeconomic groups typically experience higher chronic disease prevalence (41, 45-47). 
Comorbidities can impact on cancer survival through patient suitability for and benefit from various 
treatment options (40, 48, 49). However, a recent population-based study in the US found that 
socioeconomic disparities in breast cancer survival continued after controlling for several comorbid 
conditions (20), suggesting that variations in comorbidity cannot fully explain survival disparities.  
 
In summary, the extensive and widespread evidence presented in this review supports the 
correlation between SES and cancer survival. While survival from most cancers has increased 
over time throughout Europe, North America, Japan and Australia, the socioeconomic variations in 
survival described have generally persisted over time, in some cases since the 1970’s. The causes 
of this relationship between SES and cancer survival remain unclear, and further research is 
necessary to fully understand the associations.  
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CHAPTER 3: SOCIOECONOMIC INEQUALITIES IN CANCER SURVIVAL IN NSW 
1996-2008 
 
ABOUT THIS CHAPTER 
 
This chapter is our submitted manuscript “Cancer survival in New South Wales, Australia: 
Socioeconomic disparities remain despite overall improvements” (BMC Cancer, 2015). The 
authors of this manuscript are Julia F Stanbury, Peter D Baade, Yan Yu and Xue Qin Yu. This 
chapter analyses trends in socioeconomic survival disparities over time for ten major cancers in 
New South Wales, highlighting priority groups and the potential impact of minimising these 
disparities. 
 
 
ABSTRACT 
 
BACKGROUND Disparities in cancer survival by socioeconomic status have been reported 
previously in Australia. We investigated whether those disparities have changed over time.  
METHODS We used population-based cancer registry data for 377,493 patients diagnosed with 
one of 10 major cancers in New South Wales (NSW), Australia. Patients were assigned to an area-
based measure of socioeconomic status. Five-year relative survival was estimated for each 
socioeconomic quintile in each ‘at risk’ period (1996-2000 and 2004-2008) for the 10 individual 
cancers. Poisson-regression modelling was used to adjust for several prognostic factors. The 
relative excess risk of death by socioeconomic quintile derived from this modelling was compared 
over time.  
RESULTS Although survival increased over time for most individual cancers, Poisson-regression 
models indicated that socioeconomic disparities continued to exist in the recent period. Significant 
socioeconomic disparities were observed for stomach, colorectal, liver, lung, breast, and prostate 
cancer in 1996-2000 and remained so for 2004-2008, while significant disparities emerged for 
cervical and uterus cancer in 2004-2008 (although the interaction between period and 
socioeconomic status was not significant). About 13.4% of deaths attributable to a diagnosis of 
cancer could have been postponed if this socioeconomic disparity was eliminated. 
CONCLUSION While recent health and social policies in NSW have accompanied an increase in 
cancer survival overall, they have not been associated with a reduction in socioeconomic 
inequalities.  
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INTRODUCTION 
 
Internationally, cancer patients from more socioeconomically disadvantaged backgrounds have 
been shown to have poorer outcomes for many major cancers (1-4). Similar socioeconomic 
disparities in survival have also been reported in Australia (5, 6). In the few studies that have 
monitored such disparities over time in a population, most report either no change in the extent of 
disparities detected or widening disparities, for several major cancers (7-9). Generally these 
studies report on only one or few cancer types and involve limited adjustment for potential 
prognostic factors. 
 
In 2008, Yu et al reported that persons from more socioeconomically disadvantaged areas of 
NSW, Australia experienced poorer survival for many types of cancer than those from the least 
disadvantaged areas (6). These disparities are well recognised by health professionals and 
providers; however there is little knowledge about whether these socioeconomic disparities in 
cancer survival have reduced over time.  
 
The purpose of this study is to determine whether the socioeconomic variations in cancer survival 
for 10 major cancers in NSW, Australia have changed over time, after account for the impact of 
demographics and tumour characteristics.  
 
MATERIALS AND METHODS 
 
Data were obtained from the population-based NSW Central Cancer Registry for all patients aged 
15-89 years at the time of their diagnosis of a primary cancer between January 1991 and 
December 2008. Notification of cancer diagnosis to the registry is a statutory requirement in NSW. 
We included ten cancers with high incidence and large contribution to mortality (see Table 1), 
defined by International Classification of Diseases for Oncology 3rd Edition codes (10).  
 
Cases were followed up for survival status up to the 31 December 2008 through record linkage of 
the cancer cases in the Cancer Registry with death records from the NSW Register of Births, 
Deaths and Marriages and the National Death Index. Cases notified to the registry by death 
certificate only or first identified at post-mortem were excluded.  
 
To maintain comparability with the previously mentioned study by Yu and colleagues (6), we used 
an area-based socioeconomic measure, the “Index of Education and Occupation” score. This is a 
composite index of relative advantage, based on data from the national Australian census (11). An 
area with a high index score indicates a relatively high level of educational attainment and skilled 
employment of the resident population. For each analysis period, socioeconomic quintiles were 
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created by ranking all the Local Government Areas (LGA) in NSW by their index score from the 
2001 census, and dividing them into five groups of approximately equal population. The included 
cases were then classified into these SES quintiles based on the LGA of their residential address 
at diagnosis. In 2001 there were 175 LGAs in NSW, ranging from small urban areas with large 
populations to extremely large rural areas with small populations, each with an average population 
of 35,954 residents (IQR: 4,713 – 43,809) [ABS Online data 2001]. Cases were excluded from 
analysis if they had insufficient information to assign an LGA or if index scores were not available.  
 
Disease stage at diagnosis was based on pathology reports and statutory notifications by 
hospitals, then coded using a modified summary classification: localised (stage I), regional (a 
combination of stages II and III), distant (stage IV) and unknown (including missing) stage.  
 
Statistical Analysis  
 
Relative survival, the ratio of the observed proportion surviving in a group of cancer patients to the 
expected proportion that would have survived in an age- and sex-comparable group of people from 
the general population (12), was used in this analysis because we used all-cause mortality from a 
population-based cancer registry. Survival time for each case was calculated from the month of 
diagnosis to the month of death or censoring (31 December 2008) using life-table methods (13). 
Relative survival was calculated using the Pohar-Perme method to estimate net survival (14). We 
constructed SES-specific life tables for each year 1996-2000 and 2004-2008 by collapsing all-
cause mortality data and corresponding population data by LGA into the SES quintiles used for 
classifying cancer cases. The period method (15) was used as in the previous study (6). For each 
of these two ‘at risk’ periods (1996-2000 and 2004-2008), we calculated 5-year relative survival by 
SES quintile for 10 individual cancers. We chose the two ‘at risk’ periods for analysis to allow a 
reasonable “lead in time” from the start of the diagnostic cohort (1991) and to enable sufficient time 
for changes in survival disparity to occur. 
 
We investigated the effect of SES on survival for each cancer using multivariate modelling to adjust 
for potentially confounding variables. Firstly, we calculated the relative excess risk (RER) of death 
due to cancer using a Poisson-regression model (16). In this model, the main-effect variables were 
SES quintile, age group at diagnosis (<50 years, 50-59 years, 60-69 years, 70-79 years, 80-89 
years), sex, year of follow-up (1-5 years) and cancer stage at diagnosis. We included the natural 
logarithm of the population size as the offset (log person-year at risk) and a special link function to 
take account of background mortality. The RER derived from this model is the ratio of the excess 
risk of death in a given SES quintile to the reference SES group (the least disadvantaged quintile) 
after controlling for the other factors included in the model. Ninety-five percent confidence intervals 
(CIs) for the RERs were calculated using the estimated coefficients and standard errors from the 
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Poisson model. Secondly, we added an interaction term between SES quintile and time period to 
the model, to allow the effect of SES to change between periods and then used a likelihood ratio 
test between the nested models to determine if this interaction was significant.  
 
Finally, an estimate of the number of lives potentially extendable to 5 years from cancer diagnosis 
was calculated for the four more disadvantaged SES quintiles for each period 1996-2000 and 
2004-2008. This was done in three steps. First, for each of the four more disadvantaged quintiles, 
we calculated the difference between the number of stage-adjusted deaths within each specific 
cancer cohort and that of the age-sex equivalent group in the general population of the same 
quintile (i.e. cancer mortality minus background mortality) (17). This is the observed number of 
excess deaths. Second, we calculated the number of deaths that would have occurred if the stage-
adjusted RER of cancer death for these four quintiles equalled that of the least disadvantaged 
quintile at five years from diagnosis (6). This is the optimum number of excess deaths. Finally, the 
number of potentially extendable lives is the difference between the observed number of excess 
deaths and the optimum number of excess deaths (observed minus optimum excess deaths). This 
measure, similar to that used in the EUROCARE-4 study (18), among others (19, 20), has been 
used in different health settings and is exchangeable with “avoidable deaths” and the “number 
potentially saved” within a set time period since diagnosis. A Pearson chi-square test was then 
used to determine if the two proportions of “extendable” lives were significantly different over time. 
 
All significance tests with p-value <0.05 were taken to indicate statistical significance. Statistical 
analyses were completed using STATA software, v13.1 (StataCorp LP: College Station, TX). 
 
RESULTS 
 
A total of 380,306 cases diagnosed between 1991 and 2008 that were prevalent cases between 
periods of 1996-2000 and 2004-2008 were identified. About 0.7% (2 663 cases) were excluded 
from analysis due to being notified to the registry by death certificate only or first identified at post-
mortem, while a further 150 cases were excluded due to missing SES data. In total, 139,234 cases 
at-risk in 1996-2000 and 238,259 cases at-risk in 2004-2008 were included in the final cohort 
(Appendix B: supplementary table 1). The numbers of cases included in the analysis increased 
over time and were relatively evenly distributed across the socioeconomic quintiles in both periods. 
Liver, breast, ovarian and prostate cancers saw higher case numbers in the less disadvantaged 
SES groups, whereas the opposite trend occurred for lung cancer.  
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Table 1: Five-year relative survival (%) by socioeconomic disadvantage for 10 cancers in 
NSW, Australia, 1996-2000 and 2004-2008 
 
 
 
 
 
 
 
 
 
 
 
Relative survival increased over time for the majority of cancers, as shown in Table 1. However, 
the socioeconomic disparities observed in the first period (1996-2000) remain broadly similar in the 
late period (2004-2008). 
 
Figure 1 shows the results of the multivariable modelling: RERs by SES quintile (with the reference 
group being the least disadvantaged quintile). Values of these RER estimates and p-value of 
significance tests are presented in Table 2. During 1996-2000, the RER of death was significantly 
higher for more disadvantaged patients with stomach, colorectal, liver, lung, breast and prostate 
cancers. No significant variation in RER was found for melanoma, ovarian, cervix or uterine 
cancers. By the period of 2004-2008, significant RER’s continued to exist for, stomach, colorectal, 
liver, lung, breast, prostate cancers, while RER variations in cervical and uterine cancers became 
highly significant (p=0.008 and 0.001 respectively). Melanoma and ovarian cancer again showed 
no significant variation in RER of death by SES in 2004-2008.  
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Figure 1: Relative excess risk of death by socioeconomic status for 10 cancers in NSW, 
Australia, 2004-2008, by LGA and CD 
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The total of excess deaths due to cancer in 1996-2000 was 25,420 for all 10 cancers, of which 
2,690 lives (10.6% of excess deaths) were potentially extendable if the SES survival disparity did 
not exist (Table 3). The corresponding number for 2004-2008 increased to 26,583, of which 4,253 
lives (16.0% of excess deaths) were potentially extendable. The increase in the proportion of 
extendable lives over time was significant (p<0.001) for the majority of cancers. Lung, colorectal 
and breast cancers respectively accounted for the greatest numbers of extendable lives in both 
periods.  
 
Table 3: Number of lives that might be extended beyond 5 years from diagnosis for 10 
cancers in NSW, Australia 1996-2000 and 2004-2008 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION AND CONCLUSIONS 
 
We found that while survival for 10 cancers has either remained stable or increased over time, 
patients living in more disadvantaged areas of NSW have continued to experience lower survival 
rates than the least disadvantaged patients for cancers of the stomach, colorectum, liver, lung, 
female breast and prostate, and new disparities have emerged for cervical and uterine cancer.  
 
There are several strengths in the design and methods of this study. Our population-based data 
reflect the survival experience of people diagnosed with major types of cancer in NSW Australia. 
We used a well-established ecological study design and statistical methods, as used previously 
and recommended for measuring socioeconomic inequalities in health (6, 11). In addition, we 
provide two measures of socioeconomic disparity, one relative (RER) and one absolute (number of 
lives potentially extendable). The availability and adjustment for stage of disease at diagnosis data 
* RER coefficients are not significant in the relative survival model for specified cancer 
§ Estimated by equating the RER of death due to cancer in the four more disadvantaged quintiles to that 
of the least disadvantaged quintile and calculating the difference in the number of cancer deaths 
† Pearson chi-square test of the difference between proportions of excess deaths over time (two periods) 
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further strengthens our analysis, as stage is widely known to be an important predictor for cancer 
survival (21, 22). 
 
A limitation of our study comes from the use of aggregated area-level data to classify patients 
according to SES. Individual level socioeconomic data for cancer patients was not available for this 
study. However, recent studies using individual-level socioeconomic data detected comparable 
trends in cancer survival disparities (20, 23), suggesting a similar impact of individual and area-
based measures of SES on cancer survival. Area-level methods for measuring health disparities 
have been validated previously and were shown to appropriately detect trends in survival 
inequalities (24). In addition, the index used in this study has been extensively reviewed and 
validated using nine different methods (11) and has been widely used as a socioeconomic 
measure in numerous studies of different health outcomes in Australia (6, 25, 26).  
 
Previous research has shown that the definition of the socioeconomic index generally has little 
impact on the survival disparities detected (27). Under Australia’s universal healthcare system, 
access to health care is (theoretically) independent of a patient’s financial resources. As such, 
compared to the index used here, other income-based or economic-disadvantage indicators of 
SES may be less relevant to identifying disparities in this context.  
 
Our results of increased survival from cancer overall and continuing socioeconomic disparities in 
survival are consistent with both current Australian and international evidence. Persistent survival 
disparities by SES have been found for stomach (28), colorectal (29), liver (30), lung (1), breast (1, 
21, 31), cervical (1, 29), uterine (29) and prostate (29, 31) cancers. The reasons for the 
socioeconomic survival disparities are not thoroughly understood, and evidence on contributing 
factors is both limited and often inconclusive. Some factors thought to contribute to survival 
disparities by SES relate to differences in diagnosis and treatment factors, patient characteristics 
and health care system features (2).  
 
Previous studies of ovarian cancer survival have also found no association with SES (6, 32). The 
non-specific nature of symptoms and lack of a definitive screening-diagnostic test could explain 
this finding, as the majority of diagnoses in all socioeconomic groups in NSW in both periods 
occurred at an unknown or already advanced stage (Supplementary Table 2), by which point 
effective treatment options are limited (33). Despite Australia having the highest incidence of 
melanoma worldwide (5) we found no significant variation in survival by SES in NSW, which is 
consistent with previous findings (34). This finding is likely associated with the time–delayed effects 
of long running and effective skin cancer awareness campaigns in Australia, which have developed 
a strong culture of protective behaviours (35, 36). Patient ethnicity has been associated with both 
melanoma incidence and survival internationally (37, 38) though this data is not recorded by the 
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registry and so any potential confounding of survival rates by ethnicity could not be controlled for in 
our analysis. Australian evidence of this association is both limited and inconclusive (39). Data on 
anatomic location of melanomas was not included in this study, but previous Australian studies 
reported that melanomas most commonly occurred on the trunk and limbs, areas which have 
relatively higher survival rates (40), and that anatomic location of melanomas did not vary 
significantly by SES (34, 41).  
 
We found significant differences in the distribution of stage at diagnosis between SES groups, with 
low SES patients more often presenting at more advanced or unknown stage for several cancers 
(online supplementary table S2) as reported previously (42). This is consistent with evidence of 
lower screening participation among more disadvantaged groups in Australia (43) and 
internationally (44). However this stage differential by SES is unlikely to explain the survival 
differential observed in this study, because adjusting for spread of cancer did not greatly alter our 
estimates. While some misclassification of recorded stage information by the Registry has been 
reported (45, 46), our findings suggest that increasing early diagnosis of cancers is less important 
than improving non-diagnostic factors, such as patient lifestyle and treatment factors, in reducing 
survival disparities in NSW. Notable exceptions to this were cervical and prostate cancers, which 
both had significant survival differentials over time prior to stage adjustment that became 
insignificant after adjustment. Consequently, socioeconomic variation in rates of early diagnosis 
may be a possible contributor to disparities in cervical and prostate cancer survival.  
 
Patient lifestyle factors may impact on cancer survival by affecting overall health. Australian and 
international reports have shown that lower socioeconomic groups had significantly higher 
occurrences of poor lifestyle behaviours (47, 48). Some lifestyle factors such as smoking (48) and 
comorbidities (49) have been shown to directly impact on the benefits of cancer treatment. 
However, a recent population-based study in the US found that socioeconomic disparities in breast 
cancer survival continued after controlling for several comorbid conditions (50), suggesting that 
variations in comorbidity cannot fully explain survival disparities. While we did not specifically 
adjust for patient comorbid conditions in our study, we did use SES-specific life tables for relative 
survival calculations to reduce the effect on mortality from different levels of competing causes of 
death across the population.  
 
Variation in cancer management by SES may also contribute to disparities in survival, as patients 
of lower SES are more likely to receive sub-optimal or non-guideline therapy (21, 28). Reduced 
compliance with recommended treatment regimes in low SES patients may also contribute to lower 
survival rates (51). Australia’s universal healthcare system should provide consistent access to 
cancer treatments to all socioeconomic groups. However, it has been suggested that poorer 
survival in patients from lower socioeconomic areas in Australia is affected more by health system 
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features, such as unequal access to specialist treatment centres across NSW (52). We did not 
have access to information on treatment or patient management in this study, so we were unable 
to investigate these suggestions further. 
 
The number of lives that might be extended beyond 5 years from diagnosis has been used 
previously to highlight the importance of socioeconomic survival disparities and demonstrate the 
potential public health benefits of improving cancer services (6, 17, 20, 53). Estimating the number 
of these “avoidable deaths” (or lives “potentially saved”) can assist health authorities in allocating 
cancer services and resources to areas of greatest need, and increase attention on the need to 
further explore causes of socioeconomic variation in survival (17). The increased number of 
reported avoidable deaths over time reflects both the higher incidence and improved cancer 
survival in NSW. The observed increases in the percentage of total excess deaths that are 
avoidable emphasises the trend of persistent cancer survival disparities between socioeconomic 
groups in NSW. These results indicate that the greatest benefit would be derived from reducing 
survival disparities for lung cancer patients, and that focused health and social policies should be 
implemented to address these disparities, as suggested previously (6). Additional benefit would 
also be achieved by reducing disparities in colorectal cancer survival. 
 
In conclusion, we have reported that survival disparities by area-level SES have persisted over 
time for several cancers in NSW after adjusting for stage at diagnosis. While the causes of these 
socioeconomic disparities in survival are not thoroughly understood, variations in treatment, patient 
characteristics and health system factors may contribute. Despite increased awareness of SES 
disparities in cancer survival, and overall increases in cancer survival, this study suggests that 
recent health and social policies in NSW have not been effective in reducing socioeconomic 
inequalities in survival.  
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CHAPTER 4: MEASURING SOCIOECONOMIC DISPARITIES IN CANCERS SURVIVAL 
USING DIFFERENT GEORAPHIC AREA UNITS (Cancer Epidemiology 2015) 
 
ABOUT THIS CHAPTER 
 
This chapter is our submitted manuscript “Impact of geographic area level on measuring 
socioeconomic disparities in cancer survival in New South Wales, Australia” (Cancer 
Epidemiology, 2015). The authors of this manuscript are Julia F Stanbury, Peter D Baade, Yan Yu 
and Xue Qin Yu. This paper presents our comparison of two different area-units, LGA and CD, for 
measuring socioeconomic disparities in cancer survival detected in NSW and investigates the 
extent of misclassification by SES that may occur between these two area units, to determine 
which unit is the better alternative for measuring socioeconomic survival disparities. 
 
 
ABSTRACT  
 
BACKGROUND: Area-based socioeconomic measures are widely used in health research. In 
theory, the larger the area used the more individual misclassification is introduced, thus biasing the 
association between such area level measures and health outcomes. In this study, we examined 
the socioeconomic disparities in cancer survival using two geographic area-based measures to see 
if the size of the area matters. 
METHODS: We used population-based cancer registry data for 239,513 patients prevalent with 
one of 10 major cancers in New South Wales (NSW), Australia during 2004-2008. Patients were 
assigned index measures of socioeconomic status (SES) based on two area-level units, census 
Collection District (CD) and Local Government Area (LGA) of their address at diagnosis. Five-year 
relative survival was estimated for each socioeconomic quintile at each area-level for each cancer. 
Poisson-regression modelling was used to adjust for socioeconomic quintile, sex, age-group at 
diagnosis and disease stage at diagnosis. The relative excess risk of death (RER) by 
socioeconomic quintile derived from this modelling was compared between area-units. 
RESULTS: We found extensive disagreement in SES classification between CD and LGA levels 
across all socioeconomic quintiles, particularly for more disadvantaged groups. In general, more 
disadvantaged patients had significantly lower survival than the least disadvantaged group for both 
CD and LGA classifications. The socioeconomic survival disparities detected by CD classification 
were larger than those detected by LGA. Adjusted RER estimates by SES were similar for most 
cancers when measured at both area levels.  
CONCLUSIONS: With data confidentiality concerns increasing with the level of geographical 
precision, the observed relatively small and inconsistent impact of misclassification of LGAs on 
cancer survival disparities suggest they remain a valuable spatial unit for use in Australian health 
and social research. Greater availability of small-area level health and census data will allow for 
further methodological advances in epidemiological studies of SES and health-related outcomes. 
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INTRODUCTION 
 
Many published studies which report socioeconomic disparities in cancer survival use area-based 
measures of socioeconomic status (SES) (1, 2). Individual-level demographic data is preferable 
and most accurate, but often very difficult to obtain in population-based studies. Instead, these 
“ecological” studies use census-derived area-based measures of SES to classify patients based on 
characteristics of the aggregate population of the area in which they live. Misclassification of 
individuals may result depending on the extent of variation within the population of a specific area 
(3). Small spatial areas are known to represent more socioeconomically homogeneous populations 
compared to larger areas, primarily due to their smaller resident population and so their 
socioeconomic index values are more likely to accurately represent the characteristics of that 
population (4, 5).  
 
We previously reported socioeconomic disparities in cancer survival in New South Wales (NSW), 
Australia using Local Government Areas (LGA) to classify cases by SES (Submitted paper BMC 
Cancer 2015). LGAs are a valuable and widely used spatial unit in Australian health and social 
research, since data are readily available at this level. Compared to other spatial units in Australia, 
LGAs are considered to be ‘relatively’ small. However the use of LGAs in ecological studies has 
been criticised due to the inherent population heterogeneity within each LGA introducing potential 
misclassification of individuals (6). It is unknown to what extent this misclassification may occur 
and what impact it may have on research results. Similar misclassification effects have been 
observed in previous studies where area-based geographic units have been used (3, 5). 
Consequently, the true disparities in cancer survival in NSW may vary from those previously 
reported.  
 
Cancer incidence data from the NSW Central Cancer Registry has recently become available at 
the smaller area unit of census Collection District (CD), the smallest area unit for which a measure 
of SES is available (7). Comparing analyses of LGA and CD geocoded data will be able to more 
accurately detect and identify the extent to which cancer cases may be misclassified according to 
SES when investigating cancer survival disparities. 
 
To date, few studies have used population-based data to compare cancer survival disparities 
between area level measures (4, 5, 8). This study aims to compare the area units of CD and LGA 
to quantify the extent to which cancer patients could be misclassified by SES between these two 
area-levels and the impact of such misclassification on estimating socioeconomic disparity in 
cancer survival, with specific reference to cancer survival data in NSW in 2004-2008.  
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MATERIALS AND METHODS 
 
Data were obtained from the population-based NSW Central Cancer Registry for all patients aged 
15-89 at diagnosis of a first primary cancer between January 1999 and December 2008 that were 
prevalent cases between 2004 and 2008. Notification of a cancer diagnosis to the Registry is 
mandatory in NSW since 1972. We chose ten cancers for analysis as defined by International 
Classification of Diseases for Oncology 3rd Edition (9) codes (see Table 2). These cancers were 
chosen based on their high incidence and large contribution to population mortality. Cases were 
linked to records from the NSW State Registry of Births, Deaths and Marriages and the National 
Death Index and followed up to 31 December 2008 for survival status. Cases were excluded if 
notified to the registry by death certificate only or first identified at post-mortem. 
 
LGAs in NSW range from small urban areas with large populations to extremely large rural areas 
with small populations. In 2001 there were 175 LGAs in NSW, each with an average population of 
35,954 (IQR: 4,713-43,809) [Australian Bureau of Statistics (ABS) online data 2001]. 
Comparatively, CDs were the smallest area units used by the ABS at the time of the study period 
(2004-2008) (10), and represent a more socioeconomically homogenous population than LGAs (7). 
In 2001, NSW contained 11,510 CDs, each containing about 200 ‘dwellings’ or an average 
population of 547 residents (IQR: 369-696) [ABS data 2001].  
 
Patient SES was measured using the 2001 ABS Index of Education and Occupation score of the 
residential address at diagnosis collected by the Registry. A high index score indicates an area 
with a relatively high level of educational attainment and skilled employment in the population (10). 
This index allows us to maintain comparability with previous studies of SES and cancer survival in 
NSW (11). Two versions of this SES measure were used – the first, using aggregated 
socioeconomic quintiles created by ranking all the CDs in NSW by their index score and then 
dividing them into 5 groups of approximately equal population; the second, using quintiles created 
by LGAs aggregated in the same manner. Cases were excluded from analysis if they had 
insufficient information to assign a CD or LGA or if index scores were not available.  
 
Stage of disease at diagnosis was based on pathology reports and statutory notifications by 
hospitals, coded using a modified summary classification: localised (stage I), regional (a 
combination of stages II and III), distant (stage IV) and unknown stage.  
 
Statistical Analysis 
 
Relative survival was used in this study, which is the ratio of the observed proportion of people 
surviving 5 years in a group of cancer patients, to the expected proportion of people who would 
	  42 
have survived in a comparable group (same age and sex distribution); in this case the general 
population. Observed survival time for each case was calculated from the month of diagnosis to 
the month of death or censoring (31 December 2008) using life-table methods. Relative survival 
was calculated using the Pohar-Perme method to estimate net survival(12). We constructed LGA 
level SES-specific life tables for each year 2004-2008 using LGA level all-cause mortality data and 
the corresponding population data divided into the SES quintiles used for classifying cancer cases. 
These LGA level life tables were used in both the LGA and CD level analyses, as data of all-cause 
mortality and general population at CD level were not available.  
 
We used the same analysis strategy for both CD and LGA classification and then compared the 
two sets of results. Five-year relative survival by SES quintile for each cancer was calculated using 
the period method, to provide a more recent estimate of patient survival (13). We then investigated 
the effect of SES on survival time for each cancer using multivariate models to adjust for potentially 
confounding variables. We used a Poisson-regression model to calculate the relative excess risk 
(RER) of death due to cancer, after controlling for the other factors included in the model (14). The 
RER is the ratio of excess risk of death in a particular SES quintile compared to that of the 
reference (least disadvantaged) SES group, after controlling for the other factors. In this model, the 
main-effect variables were SES quintile, age group at diagnosis (<50 years, 50-59 years, 60-69 
years, 70-79 years, 80-89 years), sex, stage of disease at diagnosis and year of follow-up (1-5 
years), with the natural logarithm of the population size as the offset (log person-year at risk) and a 
special link function to take account of background mortality. The estimated coefficients and 
standard errors from the Poisson model were used to calculate ninety-five per-cent confidence 
intervals (CIs) for the RERs.  
 
All significance tests with p-value <0.05 were taken to indicate statistical significance. All statistical 
analysis was completed using STATA v13.1 software (StataCorp LP: College Station, TX).  
 
RESULTS  
 
A total of 239 513 cases diagnosed with one of the ten cancers between 1999 and 2008 that were 
prevalent in 2004-2008 were identified from the Registry. 944 Cases (0.4%) were excluded from 
analysis due to registry notification by death certificate only or first identified post-mortem. A further 
1,879 cases were excluded due to missing socioeconomic data. The final cohort used for analyses 
contained 236 690 cases. 
 
Table 1 shows the cross-tabulation of SES quintile by the two area levels. Assuming the smaller 
CD-specific area classification is more accurate (3-5), extensive misclassification in LGA-based 
SES can be seen across all quintiles, particularly for the 3rd and 4th CD-specific quintiles. Overall 
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agreement between the two SES level classifications was 47.3%. The highest agreement occurred 
in the least disadvantaged quintile (quintile 1), where 75.8% of cases were assigned to the same 
SES quintile using CDs and LGAs. Agreement by SES was lowest in SES quintile 3, with only 
31.1% of patients correctly classified by both area-levels. 
 
Table 1: Cross-tabulation of SES quintiles classified by LGA and CD, in NSW, Australia, 
2004-2008  
 
 
 
 
 
 
 
 
 
 
 
 
 
Relative survival rates by SES, classified by CD and LGA, for the 10 cancers are shown in Table 2. 
More disadvantaged patients with stomach, colorectal, liver, lung, breast and prostate cancers had 
significantly lower survival than the least disadvantaged group, for both CD and LGA 
classifications. In general, the survival disparities by CD classification (as measured by the range 
of quintile-specific values) were greater than those detected by LGA classification, the bias 
introduced here being towards the null hypothesis. Stomach, cervical and uterine cancers were 
notable exceptions, for which larger survival disparities were measured at the LGA level.  
 
Table 2: Relative survival by socioeconomic status for 10 cancers in NSW, Australia, 2004-
2008, by LGA and CD 
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Figure 1 further shows the variation in RER for each cancer, depicted as the RER for the four more 
disadvantaged quintiles compared to the least disadvantaged, including 95% confidence intervals. 
More variation in the RER appears for colorectal, liver and lung cancers by CD classification 
compared to LGA, whereas less variation is evident for uterine cancer by CD. The two sets of 
RERs for other cancers are fairly similar.  
 
Figure 1: Relative excess risk of death by socioeconomic status for 10 cancers in NSW, 
Australia, 2004-2008, by LGA and CD 
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The RER of death from the each cancer by SES for each area level classification is presented in 
Supplementary Table 1For most cancers, the RER disparities measured at CD level were strongly 
significant, only becoming less so when measured by LGA (see Appendix C: supplementary table 
1 for p-values). The RER of death of disadvantaged patients with melanoma and ovarian cancers 
however was significant in the CD analysis, but became insignificant in the LGA analysis. The 
opposite was observed for cervical and uterine cancers, where the RER of more disadvantaged 
patients was significant in the LGA analysis but not when measured by CD.  
 
DISCUSSION AND CONCLUSIONS 
 
We found that the widely used geographic unit in Australia (LGA) to classify patients by SES 
results in mild underestimation of the survival disparities for several cancers, compared to when 
SES is measured at CD level. Despite this however, the RER of death estimates derived from 
these survival estimates were similar in both the CD and LGA level analyses. The extremes of the 
SES quintiles were found to have higher agreement between the two area measures than 
intermediate groups, most likely because they have only one direction of potential misclassification.  
 
This study is unique in Australia, and provides important new knowledge relevant to measuring 
variations in health outcomes using area-level data. Our results contribute to growing international 
evidence supporting the preferred use of the smallest (feasible) area units available in ecological 
studies measuring health outcomes, which consistently provide results more indicative of individual 
level effects (3-5, 8, 15-18). A logical explanation for the socioeconomic misclassification observed 
here is that, since the population of each CD is smaller than that of an LGA, it is more homogenous 
in terms of socioeconomic characteristics and thus more representative of the resident population 
of that area compared to LGAs (7). Appreciating the impact of geographic scale on area level 
health research is crucial, as it allows researchers to select the most appropriate area-level data 
and provides a basis for evaluating the study results (8). 
 
Several studies have reported SES misclassification issues when investigating health related 
outcomes. Studies that compare large and small area-units to classify patient SES have shown 
similar patterns to those we report here, including studies that further compare misclassification 
between small area-unit and individual level classifications (3-5, 8). In Australia, assigning SES 
based on residential postcodes compared to CDs was found to underestimate the association 
between SES and several health-related outcomes (3). In England, socioeconomic disparities in 
breast cancer survival based on census enumeration districts were significantly larger than those 
based on electoral wards, which contain an average population of approximately ten times that of 
an enumeration districts (4). Similarly in the US, census block groups and tracts have been shown 
to detect similar socioeconomic disparities in cancer incidence and mortality, while some analyses 
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at zip-code level either failed to detect disparities or detected contradictory results (5). This was 
also reported more recently for prostate cancer mortality, where socioeconomic disparities at 
census tract and block group levels were shown to be similar to each other and both more 
indicative of individual level trends (8). These studies indicate that our results, though reporting 
only mild differences, most likely represent the true effect of socioeconomic misclassification 
between different geographic area-units. 
 
The design and methodology of our study affords it many strengths. We used population-based 
data such that the survival experience of all patients with these major cancers in NSW is 
represented. The 10 major cancers included have significant public health importance in NSW in 
terms of both morbidity and mortality for analysis. Our study is based on a well-established 
statistical methods and ecological design, as recommended and used previously for measuring 
socioeconomic health disparities (11, 19). We used the period method of calculating patient 
survival to provide the most up-to-date survival rates using the latest mortality-linked data available 
to us (13, 20). Including adjustment for stage of disease further strengthens our analysis, since 
cancer stage is known to be a strong predictor of survival (21, 22). We were unable to specifically 
adjust for patient comorbidity in this analysis, but by using SES-specific life tables we reduced the 
impact of disparities in competing causes of death in the population on our relative survival 
calculations. 
 
In addition, the index of area-level SES used here has been widely used in Australia in numerous 
studies of health outcomes and socioeconomic status (11, 23, 24) and is extensively reviewed and 
validated (10). The definition of the area-level socioeconomic index generally has minimal impact 
on survival disparities detected (4), though economic-related indicators have been shown to be 
most robust in detecting disparities in the US (5). Australia’s universal healthcare system 
(theoretically) ensures equal access to health care, so indicators based on financial-disadvantage 
or income may be less appropriate for identifying disparities in this context.  
 
A limitation of our study lies in our use of aggregated area-level data which even at CD level, the 
smallest area-unit available to us, would still carry some residual socioeconomic misclassification 
effects compared to individual SES measurements. Previous research has found small but residual 
socioeconomic misclassification between individual and small area-level analyses (3-5, 8, 25). 
Without access to individual socioeconomic data to compare with our CD-level analysis, we cannot 
quantify the extent of this remaining misclassification. Such questions are unlikely to be answered 
using routine administrative data collections, such as population-based cancer registries, that are 
not designed for detailed individual level data collections. Rather, this is an area for further 
research using large, population based cohorts providing data from both an area- and individual-
level perspective. Further to this, the SES homogeneity of quintiles used in this study could 
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potentially be questioned, considering the large population each quintile represents being similar to 
that of a large geographic area-unit. The counter argument to this point is that, since the initial 
socioeconomic classification of cases was done using smaller, more accurate area-level data 
(either by CD or LGA), the original classification remains valid and is thus more accurate than if 
classification was done using an area with a population similar to that of the final aggregated 
quintiles.  
 
Our analysis did not take into account correlations between geographic areas, the “nesting” of CDs 
within LGAs, or the impact of adjacent geographical areas. Evidence from previous studies 
suggests that accounting for geographic nesting would not have greatly altered our results or the 
socioeconomic gradients we observed (26-28). Accounting for any spatial dependence between 
neighbouring areas is an area of increasing research interest, and recent work in Australia has 
investigated the impact of spatial scales on measuring the risk of advanced breast cancer within a 
Bayesian framework (29). Further work incorporating both the hierarchical structure and special 
dependence between areas may unearth additional insights into the role of SES on cancer survival 
outcomes. We have also not examined any impact of using the alternative Statistical Local Area 
(SLA) geographic level, which also includes multiple CDs. The SLA unit has been used extensively 
in other Australian studies on geographical variation in cancer outcomes (30, 31). However, while 
some SLAs are smaller than LGAs in size, the vast majority of SLAs in NSW equated in area (and 
thus population) to a whole LGA in 2001 (7). Thus comparing survival disparities by these two area 
units would likely have produced inconclusive results.  
 
Accurate mortality data for the NSW general population was unavailable to us at CD level. At this 
small area-level, a significant proportion of death counts for individual CDs were very low and thus 
randomised for privacy reasons. Instead we used the LGA level SES-specific population life tables 
to calculate relative survival for both the LGA and CD-level analyses. As a result, the accuracy of 
our relative survival estimates at CD level is likely to be slightly diminished and this may have 
impacted on our ability to detect a significant difference between the CD-and LGA-specific RER 
estimates. 
 
In this study we found significant disparities in RER for ovarian cancer and melanoma when SES 
was assigned at CD-level, which were not detected by LGA. Previous research has reported no 
associations between survival from these cancers and SES in NSW (11, 32), though these studies 
used LGA level SES classifications and are likely to have underestimated the disparities. 
International literature however has reported survival disparities by SES for these cancers, which 
suggests our CD level analysis to be more reflective of current trends (33, 34). Conversely, we 
found significant disparities in survival for cervical and uterine cancers when SES was assigned by 
LGA-level, which were not detected at CD-level. This is despite international evidence reporting 
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SES disparities in survival from these cancers, including those using small-area and individual 
level socioeconomic information (35-37). 
 
Patients of low SES, when measured by either area unit, more often presented with more 
advanced stage in this study. Similar stage disparity by SES has been reported (38), though 
differential stage is an unlikely cause of the survival disparities we for adjusted stage in the 
modelling. Despite reports of residual misclassification of stage information recorded by the 
Registry (39, 40), it is more likely that our findings are due to disparities in non-diagnostic factors. 
 
Several arguments have been raised for and against area-level studies. Area-level measures are a 
good “building-block” for epidemiological studies, particularly those measuring health outcomes in 
large populations, as access to area-level health data is generally easier and more cost-effective 
than obtaining individual data. The population coverage is much wider for area-based such as 
retired persons, those with no occupation or income data and women in home-care roles. Privacy 
concerns surrounding patient data and anonymity are also addressed by using area-level data. 
Area-level studies allow large quantities of health information to be analysed, producing more 
reliable and generalisable results. In epidemiology, especially in large scale studies, these 
advantages of area-level data often easily outweigh the cost of potential biases, such as 
misclassification errors. Despite the potential biases, many studies have shown that area-level 
studies generally provide “appropriate” estimates of socioeconomic disparities in health as 
detected by smaller-area units or individual data (25). The risk of using larger areas, as shown 
here, is a more conservative estimate of these disparities.  
 
An additional benefit of area level studies is that they allow area-contextual effects and their impact 
on individual health outcomes to be considered, with recent research increasingly discussing these 
interactions (41-43). Whilst individual SES contributes to health outcomes (44), area level SES has 
also been shown to be associated with individual health regardless of individual level SES (15, 45-
47). The review by Frohlich and colleagues identified the two important concepts of “space” and 
“place” in health inequalities research (43). Recent interventions to reduce survival inequalities 
have not succeeded as they have not adequately addressed the role of “place” (48). This may be 
because space, the quantifiable attributes of an area, is more easily investigated as a potential 
reason for area-level health inequalities than place, being the often complex qualitative 
relationships and attitudes within a community. Greater success in reducing these inequalities may 
be achieved through future studies which focus on both space and place, and their impacts on 
health behaviours.  
 
Area-level health data, at any area scale, will continue to be used in health research as valuable 
resource to guide policy, education and planning efforts when more accurate individual level 
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information is unavailable. Appreciating the impact of geographic scale on area level health 
research is crucial, as it allows researchers to select the most appropriate area-level data and 
provides a basis for evaluating the study results. Future access to small-area level health data in 
NSW will allow for technical improvements in epidemiological studies of SES and health-related 
outcomes. Our findings suggest that while there is misclassification of area-level SES when using 
the larger LGA area compared to CD areas, the impact of this misclassification on survival 
disparities in NSW is relatively small and in no consistent direction across cancer types. As such, 
our results suggest LGAs remain a valuable spatial unit for Australian health and social research 
and are appropriate for detecting area-level socioeconomic disparities in cancer survival.  
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CHAPTER 5: DISCUSSION AND CONCLUSIONS 
 
ABOUT THIS CHAPTER 
 
This chapter presents an in-depth discussion of the research conducted and conclusions drawn 
from this thesis. Firstly, I summarise the main findings of the thesis and examine the strengths and 
limitations of the research conducted. I then discuss some potential directions for future research 
on cancer survival disparities, and how this may improve our understanding of survival disparities. 
Finally, I examine the need for ongoing monitoring of cancer survival inequalities, and bring all the 
findings from previous chapters together to discuss what the thesis contributes overall to new 
knowledge about monitoring socioeconomic inequalities in cancer survival. 
 
 
SUMMARY OF FINDINGS 
 
The papers included in this thesis have demonstrated that overall cancer survival has improved in 
NSW since 1996, but inequalities in survival by socioeconomic status persisted over the past 
decade for many cancers, despite improvements in diagnosis and treatment. Whilst 
misclassification of socioeconomic status may occur depending on the area-level unit used to 
classify patients, LGA units in NSW provide a valuable and informative measure of SES for 
analysing cancer survival disparities and tracking temporal trends in disparities.  
 
As detailed in Chapter 3, the analysis of temporal trends in socioeconomic inequalities in cancer 
survival in NSW presents the relative survival rate and relative excess risk of death by 
socioeconomic status after a diagnosis of one of ten major cancers in NSW. This paper also 
estimates the number of additional cancer patients who could have survived to 5 years if the 
excess risk of death of the least disadvantaged quintile was applied to the lower four quintiles, 
providing an absolute measure of socioeconomic survival disparities as the number of patient lives 
that were “potentially extendable” to five years from diagnosis. This measure identified cancers that 
could achieve the greatest potential benefit from targeted health and social interventions aimed at 
reducing socioeconomic survival disparities. This study found that survival inequalities by area-
level SES have persisted over time for many cancers in NSW, suggesting that current health 
strategies focussed on reducing these disparities are either not adequate or that additional factors 
contributing to survival disparities have not been properly identified and addressed by appropriate 
health strategies.  
 
In Chapter 4, I compared the estimates of relative survival and excess risk of death when SES was 
classified at area-level using two area-units of different size and populations, CD and LGA, to 
quantify the extent to which cancer patients could be misclassified by SES between these two 
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area-levels, with specific reference to cancer survival data in NSW in 2004-2008. Using LGA to 
classify patients by SES generally resulted in slight underestimation of the relative survival 
compared to when SES was measured at CD level, and similar RERs were detected at both area-
levels. As such, these findings suggest that LGAs are suitable for detecting appropriate trends in 
socioeconomic disparities in cancer survival, however attenuated, and remain a useful and 
valuable area-unit for health and social research in NSW. However, the misclassification effects 
found here require the use of LGAs and interpretation of results in future to be considered carefully 
with this point in mind. 
 
STRENGTHS AND LIMITATIONS 
 
This thesis used population-based data, with large case numbers and a long follow-up period. The 
data included 10 major cancer types of significant public health importance in NSW in terms of 
both morbidity and mortality. This data ensures the results reflect the everyday effectiveness of 
cancer treatments and patient management in NSW, such that the survival experience of all cancer 
patients in NSW is represented. 
 
The methods of analyses used in this thesis have many strengths. Firstly, the analyses are based 
on a well-established statistical method and ecological study design, as recommended and used 
previously for measuring socioeconomic health inequalities (1, 2). The period method for 
calculating relative survival was employed, which includes long patient follow-up to provide the 
most up-to-date survival estimates (3, 4). Secondly, including adjustment for stage of disease 
further strengthens the analyses by accounting for lead-time bias, considering for example, the 
impact screening may have on the observed survival time in calculations for cancers amenable to 
screening detection (5). Adjustment for stage over time in chapter 3 also accounts for length bias, 
by limiting the distortion of relative survival estimates that may result from stage migration over 
time (5). Thirdly, the socioeconomic measure “Index of Education and Occupation” has been 
widely used in numerous studies of health outcomes and socioeconomic status in Australia (1, 6, 
7) and is extensively reviewed and validated (8). Finally, the results in chapter 3 both presents two 
measures of socioeconomic disparity, one relative (RER) and one absolute (number of lives 
potentially extendable). These measures highlight the importance of socioeconomic survival 
disparities and demonstrates the potential public health benefits of improving cancer services (1, 9-
11), whilst assisting health authorities in allocating cancer care resources to areas of greatest 
need. 
 
Despite these strengths, some limitations of the data and methods use in this thesis remain. The 
primary limitation of the data is it’s aggregated area-unit nature, which would still carry some 
misclassification effects compared to individual SES measurements (12-16). The impact of patient 
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comorbidity on cancer survival estimates was not directly accounted for in the analyses as 
information on comorbid conditions are not collected by the Registry. Similarly, information on 
patient treatment regimes is also not collected, thus it was not possible to account for the impact of 
socioeconomic differences in either treatment or comorbidity on survival in this thesis. Instead, 
SES-group specific life tables were used to remove the effect on mortality from competing causes 
of death and, indirectly, the unequal distribution of comorbidity in the population. Misclassification 
of stage information by the Registry has been reported (17), therefore it is possible that the 
analyses did not fully control for cancer stage. 
 
We constructed SES-specific life tables for each year 2004-2008 using all-cause mortality data and 
the corresponding population data by LGA into the SES quintiles used for classifying cancer cases, 
as data of all-cause mortality and general population at CD level were not available. As a result, 
the accuracy of our relative survival estimates at CD level is likely to be slightly diminished and this 
may have impacted on our ability to detect a significant difference between the CD-and LGA-
specific RER estimates. Additionally, the analyses in Chapter 4 of this thesis did not take into 
account correlations between different geographic area-units – the “nesting” of CDs within LGAs – 
or the impact of adjacent geographical areas, though doing so would not have greatly altered the 
socioeconomic gradients observed (18-20).  
 
FUTURE RESEARCH DIRECTIONS 
 
There are several ways in which research monitoring socioeconomic inequalities in cancer survival 
could be improved in future to more accurately inform attempts to reduce the survival disparities. 
These include: conducting large population-based cohort studies of cancer survival which use both 
individual and area-level data; Availability of small area-level population mortality data; Application 
of varying statistical methods to similar studies to accounting for issues of area-unit adjacency and 
spatial dependence; and increased examination of the impact of area-contextual effects on health 
and their links with cancer survival inequalities. 
 
Without access to individual socioeconomic data to compare with area-level analyses, we cannot 
quantify the extent of this remaining misclassification and the possible associations with cancer 
survival working at each level. Future studies including data on patient comorbidities, tumour 
characteristics, treatment and compliance with therapy are needed to clarify the extent to which 
clinical and patient factors may impact on survival inequalities. This is an area for future research 
using large, population based cohort studies that offer both area- and individual-level data 
socioeconomic data for comparison. 
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Misclassification of stage information recorded by the Registry has been reported previously (17, 
21), More accurate recording of stage data by the registry, as well as tumour size and histology 
information, would benefit the understanding of both improvements in survival over time and the 
progression of survival disparities over time, by ensuring the effects of stage at diagnosis and 
tumour characteristics are accurately accounted for in analyses. 
 
Privacy concerns surrounding patient data and anonymity precluded access to NSW population 
mortality data at an area-level smaller than LGA for analysis in Chapter 4. Future access to small-
area level health data in NSW will allow for technical improvements in epidemiological studies of 
SES and health-related outcomes.  
 
Accounting for spatial dependence between neighbouring areas and “nesting” effects is an area of 
increasing research interest, and recent work in Australia has investigated the impact of spatial 
scales on measuring the risk of advanced breast cancer within a Bayesian framework (22). Further 
work incorporating both the hierarchical structure and spatial dependence between areas may 
provide additional insights into the impact of SES on cancer survival.  
 
Due to the ecological study design of the analyses in this thesis, it cannot be concluded from this 
research that an individual person’s SES is directly associated with lower cancer survival in NSW. 
The larger area-level socioeconomic measures are likely to be less reflective of the characteristics 
of individual patients living within an areas, rather more reflective of the characteristics of the 
community in each area as a whole. Hence, the characteristics of the community within area-units 
may potentially be the basis for socioeconomic inequalities in cancer survival. Increasingly, recent 
literature has focused on the correlation between these area contextual effects and individual 
health outcomes (23-25). Whilst individual SES contributes to health outcomes (26), area level 
SES has also been shown to be associated with individual health regardless of individual level 
SES (27-30). These few studies that have compared the impact of individual and area-level SES 
on cancer survival report that individual and area-level SES are both independently related to 
cancer survival, but also interact. The concepts of “space”, the measurable attributes of an area, 
and “place”, the qualitative relationships and attitudes within a local community, were identified by 
Frohlich and colleagues in a review of research on health inequalities (25). They concluded from 
this review that there has been limited success in reducing survival inequalities because the role of 
space has been more easily and thoroughly addressed than the multi-layered role of Place, as a 
potential reason for area-level health inequalities. Future studies of cancer survival inequalities 
which focus on both the quantifiable “space” characteristics and more qualitative community-based 
“place” characteristics, such as differential access to specialised healthcare, and their impacts on 
health behaviours may yield greater success in highlighting reasons for, and ultimately reducing, 
socioeconomic inequalities in cancer survival.  
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CONCLUSIONS  
 
This thesis emphasizes the importance of assessing progress toward eliminating cancer survival 
inequalities for two reasons. Firstly, monitoring these disparities assists the overall monitoring of 
improvements in cancer survival and is essential for identifying those groups more vulnerable to a 
poorer cancer prognosis. Secondly, monitoring survival disparities is important as it provides the 
opportunity to examine the impacts of the many proposed causes of socioeconomic inequalities in 
cancer survival.  
 
The findings of this thesis have important implications for predicting and planning for the future 
needs of cancer care services in NSW, thus informing health and social policies aiming to reduce 
the socioeconomic inequalities in cancer survival in NSW. This thesis also contributes to the field 
of epidemiology by improving our understanding of the impact of using area-based measures of 
differing geographical precision when investigating socioeconomic inequalities in health outcomes. 
These findings add to growing international evidence supporting the preferred use of the smallest 
(feasible) area units available in ecological studies measuring health outcomes. 
 
The analysis in Chapter 3 shows that while recent health and social policies have accompanied an 
increase in cancer survival overall in NSW, they have not been associated with a reduction in 
socioeconomic inequalities. Survival has increased over time for most individual cancers, but 
significant socioeconomic disparities persisted over the study period for stomach, colorectal, liver, 
lung, breast, and prostate cancers, whilst disparities in cervical and uterine cancers have emerged 
in recent years. More disadvantaged patients generally experienced poorer survival and large 
numbers of patient lives would be potentially extendable if these inequalities were reduced. 
Appreciating the impact of geographic scale on area level health research is crucial, as it allows 
researchers to select the most appropriate area-level data and provides a basis for evaluating the 
study results (12). The analysis in Chapter 4 found extensive disagreement in SES classification 
across all socioeconomic quintiles between data classified at LGA and CD area-levels, and 
particularly for more disadvantaged groups. Again, more disadvantaged patients experienced 
significantly lower survival at both LGA and CD classifications, though our analysis detected similar 
RERs at both area-levels. These findings suggest that LGAs detect appropriate, though 
attenuated, patterns in socioeconomic disparities in cancer survival, and remain a useful and 
valuable area-unit for health and social research in NSW.  
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